Aether Biomachines, the company reindustrializing America by turning AI-designed proteins into real-world solutions, announced an additional $15M in funding led by Tribe Capital, with participation from new and existing investors including Natural Capital, Henkel Corporation, Resilience Reserve, Shrug Capital, 4DX Ventures, Unless Partners, and Radicle Impact. The round brings Aether's total funding to $64 million.